Emma E van Daalen1, J Charles Jennette2, Stephen P McAdoo3, Charles D Pusey3, Marco A Alba2, Caroline J Poulton4, Ron Wolterbeek5, Tri Q Nguyen6, Roel Goldschmeding6, Bassam Alchi7, Meryl Griffiths8, Janak R de Zoysa9, Beula Vincent9, Jan A Bruijn10, Ingeborg M Bajema10. 1. Departments of Pathology and e.e.van_daalen@lumc.nl. 2. Department of Pathology and Laboratory Medicine and. 3. Renal and Vascular Inflammation Section, Department of Medicine, Imperial College London, Hammersmith Hospital, London, United Kingdom. 4. Kidney Center, Division of Nephrology and Hypertension, Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina. 5. Medical Statistics and Bioinformatics, Leiden University Medical Center, Leiden, The Netherlands. 6. Department of Pathology, University Medical Center Utrecht, Utrecht, The Netherlands. 7. Renal Department, Royal Berkshire Hospital, Reading, Berkshire, United Kingdom. 8. Department of Histopathology, Addenbrooke's Hospital, Cambridge, United Kingdom; and. 9. Department of Nephrology, North Shore Hospital, Auckland, New Zealand. 10. Departments of Pathology and.
Abstract
BACKGROUND AND OBJECTIVES: Large studies on long-term kidney outcome in patients with anti-glomerular basement membrane (anti-GBM) GN are lacking. This study aimed to identify clinical and histopathologic parameters that predict kidney outcome in these patients. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: This retrospective analysis included a total of 123 patients with anti-GBM GN between 1986 and 2015 from six centers worldwide. Their kidney biopsy samples were classified according to the histopathologic classification for ANCA-associated GN. Clinical data such as details of treatment were retrieved from clinical records. The primary outcome parameter was the occurrence of ESRD. Kidney survival was analyzed using the log-rank test and Cox regression analyses. RESULTS: The 5-year kidney survival rate was 34%, with an improved rate observed among patients diagnosed after 2007 (P=0.01). In patients with anti-GBM GN, histopathologic class and kidney survival were associated (P<0.001). Only one of 15 patients with a focal class biopsy sample (≥50% normal glomeruli) developed ESRD. Patients with a sclerotic class biopsy sample (≥50% globally sclerotic glomeruli) and patients with 100% cellular crescents did not recover from dialysis dependency at presentation. In multivariable analysis, dialysis dependency at presentation (hazard ratio [HR], 3.17; 95% confidence interval [95% CI], 1.59 to 6.32), percentage of normal glomeruli (HR, 0.97; 95% CI, 0.95 to 0.99), and extent of interstitial infiltrate (HR, 2.02; 95% CI, 1.17 to 3.50) were predictors of ESRD during follow-up. CONCLUSIONS: Dialysis dependency, low percentage of normal glomeruli, and large extent of interstitial infiltrate are associated with poor kidney outcome in anti-GBM GN. Kidney outcome has improved during recent years; the success rate doubled after 2007. PODCAST: This article contains a podcast at https://www.asn-online.org/media/podcast/CJASN/2017_11_21_CJASNPodcast_18_1_v.mp3.
BACKGROUND AND OBJECTIVES: Large studies on long-term kidney outcome in patients with anti-glomerular basement membrane (anti-GBM) GN are lacking. This study aimed to identify clinical and histopathologic parameters that predict kidney outcome in these patients. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: This retrospective analysis included a total of 123 patients with anti-GBM GN between 1986 and 2015 from six centers worldwide. Their kidney biopsy samples were classified according to the histopathologic classification for ANCA-associated GN. Clinical data such as details of treatment were retrieved from clinical records. The primary outcome parameter was the occurrence of ESRD. Kidney survival was analyzed using the log-rank test and Cox regression analyses. RESULTS: The 5-year kidney survival rate was 34%, with an improved rate observed among patients diagnosed after 2007 (P=0.01). In patients with anti-GBM GN, histopathologic class and kidney survival were associated (P<0.001). Only one of 15 patients with a focal class biopsy sample (≥50% normal glomeruli) developed ESRD. Patients with a sclerotic class biopsy sample (≥50% globally sclerotic glomeruli) and patients with 100% cellular crescents did not recover from dialysis dependency at presentation. In multivariable analysis, dialysis dependency at presentation (hazard ratio [HR], 3.17; 95% confidence interval [95% CI], 1.59 to 6.32), percentage of normal glomeruli (HR, 0.97; 95% CI, 0.95 to 0.99), and extent of interstitial infiltrate (HR, 2.02; 95% CI, 1.17 to 3.50) were predictors of ESRD during follow-up. CONCLUSIONS: Dialysis dependency, low percentage of normal glomeruli, and large extent of interstitial infiltrate are associated with poor kidney outcome in anti-GBM GN. Kidney outcome has improved during recent years; the success rate doubled after 2007. PODCAST: This article contains a podcast at https://www.asn-online.org/media/podcast/CJASN/2017_11_21_CJASNPodcast_18_1_v.mp3.
Authors: Mark Canney; Paul V O'Hara; Caitriona M McEvoy; Samar Medani; Dervla M Connaughton; Ahad A Abdalla; Ross Doyle; Austin G Stack; Conall M O'Seaghdha; Michael R Clarkson; Matthew D Griffin; John Holian; Anthony M Dorman; Aileen Niland; Mary Keogan; Eleanor M Wallace; Niall P Conlon; Cathal Walsh; Alan Kelly; Mark A Little Journal: Clin J Am Soc Nephrol Date: 2016-07-11 Impact factor: 8.237
Authors: J C Jennette; R J Falk; P A Bacon; N Basu; M C Cid; F Ferrario; L F Flores-Suarez; W L Gross; L Guillevin; E C Hagen; G S Hoffman; D R Jayne; C G M Kallenberg; P Lamprecht; C A Langford; R A Luqmani; A D Mahr; E L Matteson; P A Merkel; S Ozen; C D Pusey; N Rasmussen; A J Rees; D G I Scott; U Specks; J H Stone; K Takahashi; R A Watts Journal: Arthritis Rheum Date: 2013-01
Authors: Marina Sánchez-Agesta; Cristina Rabasco; María J Soler; Amir Shabaka; Elisabeth Canllavi; Saulo J Fernández; Juan M Cazorla; Esperanza López-Rubio; Ana Romera; Sergio Barroso; Ana Huerta; Leonardo Calle; Milagros Sierra; Patricia Domínguez-Torres; Manuela Moreno-Ramírez; Sara Afonso; Victoria Mascarós; Armando Coca; Mario Espinosa Journal: Front Med (Lausanne) Date: 2022-07-05
Authors: Fredrik Uhlin; Wladimir Szpirt; Andreas Kronbichler; Annette Bruchfeld; Inga Soveri; Lionel Rostaing; Eric Daugas; Arnaud Lionet; Nassim Kamar; Cédric Rafat; Marek Mysliveček; Vladimír Tesař; Anders Fernström; Christian Kjellman; Charlotte Elfving; Stephen McAdoo; Johan Mölne; Ingeborg Bajema; Elisabeth Sonesson; Mårten Segelmark Journal: J Am Soc Nephrol Date: 2022-03-08 Impact factor: 14.978